Research Intelligence & Discovery - software & AI news

Daily news on software, AI, and companies shaping research intelligence & discovery.

Showing 51 results
A petri dish with T cells in a dimly lit lab setting.

Jun 25, 2026

Immunai Signs Discovery Deal With Boehringer Ingelheim

Immunai, an AI-driven biotech company based in Israel, has entered into a significant discovery collaboration with Boehringer Ingelheim, a major German pharmaceutical firm. This partnership is valued at up to $15 million and is scheduled to continue through 2027.The collaboration will leverage Immunai's advanced single-cell AI platform to analyze T cells from a vast array of patient samples related to cancer and autoimmune diseases. The goal is to uncover common patterns of T-cell dysfunction th
A minimalist illustration of a test tube and microscope in a lab setting.

Jun 18, 2026

OpenAI launches LifeSciBench to evaluate AI in life sciences

OpenAI has introduced LifeSciBench, a robust benchmarking tool designed to assess AI models in real-world life sciences research environments.This new tool, launched on June 17, consists of 750 expert-developed tasks that encompass the complexities of biological research workflows, moving beyond simplified textbook scenarios. The tasks cover seven key workflows including evidence handling, scientific reasoning, and communication, reflecting the multifaceted nature of daily research conducted by
A test tube with a colorful liquid in a dark lab setting

Jun 15, 2026

Cleveland Clinic and IBM Forum Highlights Advancements in AI and Quantum Computing for Healthcare Research

The Cleveland Discovery and Innovation Forum, co-hosted by Cleveland Clinic and IBM, showcased significant advancements in the integration of AI and quantum computing within healthcare research. This event gathered global experts to discuss how these technologies are transforming patient care and accelerating scientific discovery.The forum featured over 30 speakers from various sectors, including academia and industry, who addressed the implications of AI and quantum computing in overcoming comp
A minimalist illustration of a pipette with a droplet, symbolizing scientific experimentation.

Jun 9, 2026

PromptBio Launched All-New Agentic AI Platform For Life Sciences, Turning Scientific Intent Into Executable Experiments

PromptBio has unveiled its innovative Agentic AI Platform, designed to transform scientific intent into actionable experiments, streamlining the research process in life sciences.This new platform integrates conversational AI with a multi-agent orchestration system, allowing researchers to formulate and execute complex analyses using natural language. By automating the design of workflows, data analysis, and interpretation of results, the platform aims to significantly cut down the time and effo
A research notebook and pen in a lab setting

Jun 3, 2026

Accelerating life sciences research with Kiro: A unified AI interface to 100+ open source databases

Researchers in life sciences often grapple with the daunting task of integrating data from numerous databases, each with unique access protocols and formats. Kiro for Life Sciences addresses this challenge by offering a unified AI interface that connects over 100 databases across 24 disciplines, enabling researchers to query multiple sources simultaneously using natural language.The integration of disparate databases can be overwhelming. For example, a researcher studying BRCA1 variants may need
A minimalist illustration of a molecule representing drug development.

Jun 3, 2026

Ingenix Raises €13m From Sofinnova Partners-Led Syndicate to Scale Modality Fusion, a Novel Architecture for Drug Development

Ingenix has successfully secured €13 million in funding to advance its innovative Biological Reasoning Engine, which utilizes a novel AI architecture called Modality Fusion for drug development.This funding round, led by Sofinnova Partners with additional contributions from Inovo VC and OTB VC, aims to enhance Ingenix's collaborations with pharmaceutical and biotech companies through its newly launched Qualified Access Program. The Biological Reasoning Engine has demonstrated impressive capabili
A flat representation of a clinical trial document

Jun 2, 2026

Argon AI Raises $5.5M To Bring Structure to Biopharma

Argon AI has successfully secured $5.5 million in funding to enhance accessibility and usability of biopharma knowledge.The startup aims to address the rising complexity within the biopharmaceutical sector, where the number of clinical trials has surged by 70% and medical literature has increased by 58% in recent years. This rapid growth presents significant challenges for professionals trying to navigate the vast amount of information available.By leveraging artificial intelligence, Argon AI se
A minimalist workflow diagram in a dark palette with lime accents.

May 28, 2026

Causaly Introduces Scientific Workflows to Turn Expert Scientific Methods into Repeatable, AI-Executed Processes in Life Sciences

Causaly has launched Scientific Workflows, a new feature in its AI platform aimed at transforming expert scientific methods into standardized, autonomous workflows for life sciences organizations.This innovative solution allows biopharma R&D teams to codify their research processes into structured workflows that AI can execute consistently. By doing so, it produces reliable outputs such as target assessments and safety dossiers, enabling teams to scale their research methodologies and enhance de
A minimalist illustration of a dollar sign and a coin in a dark palette.

May 27, 2026

Cypher AI Raises $2M in Seed Funding

Cypher AI, a company focused on AI-driven digital infrastructure for life sciences R&D, has successfully secured $2 million in Seed funding.This funding round was led by MaC Venture Capital, with contributions from several investors including Epsilon Ventures, Connecticut Innovations, Sparta Group, and LiquidMetal Ventures. The capital will be directed towards enhancing the company's operations and advancing its development projects.Founded in 2025 by Yaoyu Yang, Cypher AI aims to transform the
A vial of a drug compound in a laboratory setting

May 22, 2026

Microsoft & Novo Nordisk: Accelerating Pharma R&D With AI

The collaboration between Microsoft and Novo Nordisk aims to transform pharmaceutical research and development by leveraging artificial intelligence to streamline processes and enhance data utilization.As the pharmaceutical industry faces escalating research and development costs alongside fierce competition, there is a pressing need to derive insights quickly from existing data. Traditionally, answering scientific questions in R&D has required extensive collaboration among various experts, incl
A minimalist illustration of a DNA strand on a solid background.

May 22, 2026

Agentic Biotech Platform Patterns

Microsoft has launched the Microsoft Discovery platform, aimed at revolutionizing AI-driven biotech research.This new enterprise solution integrates agentic automation, advanced graph-based knowledge systems, and high-performance computing tailored for the unique needs of regulated scientific environments. Key features include tenant deployment, provenance tracking, and secure model fine-tuning, which facilitate the integration of proprietary datasets and tools.Microsoft emphasizes the platform'
A test tube in a dimly lit lab, symbolizing biopharma research.

May 20, 2026

Cohere Acquires Reliant AI To Expand Into Biopharma And Healthcare

Cohere has announced its acquisition of Reliant AI, a strategic move aimed at enhancing its presence in the biopharma and healthcare sectors. This acquisition integrates Reliant AI’s specialized biomedical datasets and technology into Cohere’s enterprise AI platform, which is tailored for industries with stringent security and compliance requirements.The deal not only strengthens Cohere's foothold in Canada and Germany but also boosts its expansion efforts throughout Europe. By leveraging Relian